Cargando…
Ferroptosis in osteosarcoma: A promising future
The incidence of osteosarcoma (OS) is increasing year by year, and the prognosis of patients with advanced OS is extremely poor due to the tendency of recurrence and chemotherapy resistance after surgery. Ferroptosis is a novel form of programmed cell death (PCD) that kills cells through iron-depend...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705963/ https://www.ncbi.nlm.nih.gov/pubmed/36457488 http://dx.doi.org/10.3389/fonc.2022.1031779 |
_version_ | 1784840401521213440 |
---|---|
author | Liu, Xiang Du, Shaowen Wang, Shengdong Ye, Kaishan |
author_facet | Liu, Xiang Du, Shaowen Wang, Shengdong Ye, Kaishan |
author_sort | Liu, Xiang |
collection | PubMed |
description | The incidence of osteosarcoma (OS) is increasing year by year, and the prognosis of patients with advanced OS is extremely poor due to the tendency of recurrence and chemotherapy resistance after surgery. Ferroptosis is a novel form of programmed cell death (PCD) that kills cells through iron-dependent lipid peroxidation. Current studies have shown that ferroptosis is closely related to OS and could reduce chemotherapy resistance to a certain extent, which has great therapeutic potential. In this paper, we review the regulatory mechanism of ferroptosis and its research progress in OS, hoping to provide new help for the clinical treatment of OS. |
format | Online Article Text |
id | pubmed-9705963 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97059632022-11-30 Ferroptosis in osteosarcoma: A promising future Liu, Xiang Du, Shaowen Wang, Shengdong Ye, Kaishan Front Oncol Oncology The incidence of osteosarcoma (OS) is increasing year by year, and the prognosis of patients with advanced OS is extremely poor due to the tendency of recurrence and chemotherapy resistance after surgery. Ferroptosis is a novel form of programmed cell death (PCD) that kills cells through iron-dependent lipid peroxidation. Current studies have shown that ferroptosis is closely related to OS and could reduce chemotherapy resistance to a certain extent, which has great therapeutic potential. In this paper, we review the regulatory mechanism of ferroptosis and its research progress in OS, hoping to provide new help for the clinical treatment of OS. Frontiers Media S.A. 2022-11-15 /pmc/articles/PMC9705963/ /pubmed/36457488 http://dx.doi.org/10.3389/fonc.2022.1031779 Text en Copyright © 2022 Liu, Du, Wang and Ye https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Liu, Xiang Du, Shaowen Wang, Shengdong Ye, Kaishan Ferroptosis in osteosarcoma: A promising future |
title | Ferroptosis in osteosarcoma: A promising future |
title_full | Ferroptosis in osteosarcoma: A promising future |
title_fullStr | Ferroptosis in osteosarcoma: A promising future |
title_full_unstemmed | Ferroptosis in osteosarcoma: A promising future |
title_short | Ferroptosis in osteosarcoma: A promising future |
title_sort | ferroptosis in osteosarcoma: a promising future |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705963/ https://www.ncbi.nlm.nih.gov/pubmed/36457488 http://dx.doi.org/10.3389/fonc.2022.1031779 |
work_keys_str_mv | AT liuxiang ferroptosisinosteosarcomaapromisingfuture AT dushaowen ferroptosisinosteosarcomaapromisingfuture AT wangshengdong ferroptosisinosteosarcomaapromisingfuture AT yekaishan ferroptosisinosteosarcomaapromisingfuture |